EQUIP supports the United States Agency for International Development’s (USAID) commitment, through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), to end the HIV/AIDS epidemic. With novel approaches to fast-tracking cost-effective treatment and prevention initiatives, EQUIP supports rapid diagnosis and successful linkage to sustained treatment for people living with HIV (PLHIV), ultimately working towards the UNAIDS 90-90-90 targets.
EQUIP was founded in October 2015 in response to a call from USAID to establish a rapid-response mechanism to assist PEPFAR countries to achieve their 90-90-90 targets. EQUIP is the first African-led global consortium to deliver rapid scale-up of innovative HIV treatment and preventions solutions across 17 PEPFAR countries. Supported by USAID through PEPFAR, EQUIP applies its model for rapid scale-up and technical assistance across 17 PEPFAR countries in Africa, the Caribbean, Eastern Europe and South East Asia.
It coordinates with country stakeholders—Ministries of Health, USAID country Missions and local implementing partners—to strengthen health care systems, roll out Test & Start, scale-up viral load monitoring and self-testing and evaluate outcomes, costs, and cost-effectiveness. Through implementation science and demonstration studies, EQUIP enables countries to find efficient, scalable solutions to finding populations in need and delivering services to them.
Right to Care serves as the prime partner for the EQUIP consortium—a powerful collaboration of leading African organizations—that includes Anova Health Institute, Maternal Adolescent and Child Health (MatCH) and Kheth’impilo, based in South Africa, and Partners in Hope based in Malawi.
Additional academic support was brought on board to strengthen the operational research component of EQUIP, from partners at the Health Economics and Epidemiology Research Office (HE²RO) of the Wits Health Consortium at Witwatersrand University, the National Health Laboratory Service (NHLS) in South Africa, and Boston University (BU), and the University of California Los Angeles (UCLA) in the United States. Combined, the consortium brings decades of experience delivering high quality HIV services. Most of all, the partnership organizations invest their unique expertise in innovating novel approaches to service delivery, guideline improvement, implementing monitoring and evaluation processes and assessing cost effectiveness and sustainable outcomes, contextualized to each country setting.